The collected data suggest that PRL, including that produced locally in the prostate gland, should be considered a promoter of benign and malignant prostate tumors, and the autocrine and paracrine mechanism itself should be considered a new therapeutic approach (178, 180)
For those dealing with persistent pain from old injuries or chronic conditions, these peptides can help address the underlying inflammation and tissue damage that contribute to your symptoms
In some embodiments, following the isolation of the microspheres from the continuous-phase processing medium, the remainder of the solvent in the microspheres is removed by extraction
Common protocols reference BPC 157 at 200500 mcg daily and TB 500 with a 46 mg/week loading phase followed by 24 mg/week maintenance, typically via subcutaneous injection
Lets break down the facts so you can understand the best approach for your needs
Who should avoid taking sermorelin